Back

EMA601 and glenzocimab: two glycoprotein VI inhibitory Fabs with different potency

European Heart Journal

2 April 2025
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on pharmacotherapy for acute coronary syndromes
thumbnail
Congress Presentation
Medical treatment works! Contemporary implementation into clinical practice
thumbnail
Congress Presentation
The cardiovascular polypill: simplicity to tackle a complex problem

ESC 365 is supported by

novartis Explore sponsored resources